COVID-19 UPDATE: Medlab will continue warehouse operations, delivery and customer service. For more information please contact us by phone (1300 369 570), email ([email protected]) or, you can speak to one of our in house Naturopaths at our virtual clinic (clinic.medlab.co)
Medlab is SUPER PROUD to be participating again in the Children’s Cancer Institute’s CEO Dare to Cure 2020! This fundraiser is close to our hearts, and it’s roots are deep within our legacy.. that’s why we’ve got not 1 but.. 6 of our best leaders participating! Dr Sean Hall our CEO, Alan Dworkin our CFO, Dr Patrick Mueller our Director of Regulatory Affairs, Tony Potter our GM of Pharmaceuticals, Varun Mehta our National Sales Manager and Anna Spyropoulos our Head of Human Resources.
Please support us by donating on fundraising pages:
Dr Sean Hall, Alan Dworkin, Dr Patrick Mueller, Tony Potter, Varun Mehta, Anna Spyropoulos,
Medlab CEO Dr Sean Hall contributes opinion piece to Research Australia’s first INSIGHTS series of Leadership Opinion Editorials.
This edition shares insights on the immediacy of dealing with the pandemic challenges and how we can make things better as a result, whether it is in aged care or getting products to market.
Read Innovation needs funding to reach the market- the challenges are real here.
Medlab Clinical CEO Dr. Sean Hall announces plans for expansion into Europe
Medlab Open Day - 5th December 2018
Medicinal Cannabis Milestone
Ross Greenwood speaks to Medlab CEO Sean Hall about the first successful shipment of cannabis-based medicine, NanaBis. (NanaBisTM is an investigative new product containing 1:1 ratios of Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), delivery in a sub micron spray to the oro-buccal membrane.)
.png)
